Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up

Benzer Materyaller

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  Yazar:: Caorsi, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  Yazar:: Caorsi, Roberta, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  Yazar:: Bibalo, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
  Yazar:: Toker, Ori, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
  Yazar:: Svetlana Olegovna Salugina, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-12-01)